The intriguing world of cannabinoids has been the subject of scientific fascination for its multifaceted effects on the human body and mind. Recently, the spotlight has turned towards understanding how these natural compounds affect sleep and whether they hold the...
Read moreUnleashing the Calming Power of CBD for PTSD: Revealing the Stunning Results from a Landmark Case Series. π§ͺπΏ In a groundbreaking case series, scientists studied the fascinating role of Cannabidiol (CBD) in treating Post-Traumatic Stress Disorder (PTSD). The researchers took...
Read moreIn a groundbreaking study, scientists may have found a novel approach to manage alcohol tolerance β and it comes down to Cannabidiol (CBD). This non-psychoactive component of the cannabis plant might hold the key to maintaining a stable equilibrium in...
Read more
You’re Not Taking the Right Dose Finding the correct dosage of CBD is complicated. “CBD at the tiny doses that people are taking (10 to 40 milligrams) is simply not effective,” said Jordan Tishler, MD, a Harvard physician, cannabis therapeutics Read more…
This comprehensive study, available on PubMed Central, examines the potential of targeting endocannabinoid degradation enzyme inhibitors for the development of new antipsychotic medications. Schizophrenia and other psychotic disorders often lack effective treatments with minimal side effects, driving the need for Read more…
Recent research published under the title “Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients” has revealed promising results regarding the use of medical cannabis among those undergoing palliative care for cancer. The study, accessible through the Read more…
Schizophrenia and related psychotic disorders pose significant challenges in contemporary psychiatry, necessitating the exploration of novel therapeutic approaches. Recent research has turned towards the endocannabinoid system and its role in psychiatric disorders. Notably, endocannabinoid degradation enzyme inhibitors have emerged as Read more…
Recent research has highlighted the significant therapeutic potential of Cannabidiol (CBD) in managing social stress and enhancing emotional support among patients. This summary delves into the comprehensive study published in the National Center for Biotechnology Information (NCBI), which investigates how Read more…
Parkinsonβs disease (PD) is a progressive neurodegenerative disorder marked by the loss of dopamine-producing neurons in the brain, leading to motor and non-motor symptoms. Recent research has explored the therapeutic potential of cannabidiol (CBD), a non-psychoactive compound found in cannabis, Read more…
Arthritis, characterized by debilitating inflammation and chronic pain, significantly impacts the quality of life for millions globally. Recent research has highlighted a promising therapeutic approach using transdermal cannabidiol (CBD). In a study published by NCBI, the efficacy of transdermal CBD Read more…
Cannabidiol (CBD), a non-psychoactive compound found in cannabis, has garnered significant attention due to its potential therapeutic effects across a variety of conditions. One of the critical pathways through which CBD exerts these effects is by enhancing anandamide signaling within Read more…
In a groundbreaking study published in the National Center for Biotechnology Information, researchers delve deep into the multifaceted benefits of cannabis and its derived compounds, especially focusing on their antimicrobial properties and how these attributes could mark a turning point Read more…
In recent years, there has been a growing body of research focused on the intersection of cannabis use and mental health disorders, often termed as dual diagnoses. However, less attention has been given to how these interactions and outcomes differ Read more…
